Skip Navigation

Neuro-Oncology 2007 9(3):326-334; doi:10.1215/15228517-2007-005
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Holick, C. N.
Right arrow Articles by Michaud, D. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Holick, C. N.
Right arrow Articles by Michaud, D. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Society for Neuro-Oncology

Prospective study of cigarette smoking and adult glioma: Dosage, duration, and latency

Crystal N. Holick, Edward L. Giovannucci, Bernard Rosner, Meir J. Stampfer and Dominique S. Michaud

Departments of Nutrition (C.N.H., E.L.G., M.J.S.), Epidemiology (E.L.G., M.J.S., D.S.M.), and Biostatistics (B.R.), Harvard School of Public Health, Boston, MA 02115; and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital (E.L.G., B.R., M.J.S., D.S.M.), Harvard Medical School, Boston, MA 02115; USA

Address correspondence to Crystal N. Holick, Sc.D., MPH, Fred Hutchinson Cancer Center, 1100 Fairview Avenue North (M4-B402), Seattle, WA 98109, USA (cholick{at}fhcrc.org).


   Abstract

Tobacco products are major contributors of exogenous N-nitroso compounds, a group of potent neurocarcinogens. Overall results from studies of smoking and brain tumors have been null, but have provided little information on duration, age at smoking initiation, and latency. We prospectively examined the relation between cigarette smoking and glioma risk among men and women in three large U.S. cohort studies: the Health Professionals Follow-up Study (HPFS), the Nurses' Health Study I (NHS), and NHS II. Information on smoking history was obtained at baseline (1986 for HPFS, 1976 for NHS, and 1989 for NHS II) and updated biennially through 2002 in the HPFS and the NHS and 2003 in the NHS II. We confirmed 110 incident gliomas among men and 255 gliomas among women during 667,673 and 4,388,515 person-years of follow-up, respectively. Cox proportional hazard models were used to estimate incidence rate ratios and 95% confidence intervals between smoking and glioma risk adjusting for age, total meat intake, and alcohol and coffee consumption. Estimates from each cohort were pooled using a random-effects model after determining that there was no heterogeneity by sex. No association with glioma risk was observed between baseline or updated smoking status, intensity, duration, or age at smoking initiation among men and women. Furthermore, no association with glioma risk was observed after allowing for an induction period between smoking and glioma diagnosis. These findings provide strong evidence that cigarette smoking is not associated with an appreciably elevated risk of adult glioma.

Keywords: cigarette smoking, epidemiology, glioma, prospective studies

Received July 27, 2006; Accepted November 28, 2006


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
D. S Michaud, C. N Holick, T. T Batchelor, E. Giovannucci, and D. J Hunter
Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma
Am. J. Clinical Nutrition, September 1, 2009; 90(3): 570 - 577.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.